Zu‐De Xu

1.5k total citations
28 papers, 1.3k citations indexed

About

Zu‐De Xu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zu‐De Xu has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Zu‐De Xu's work include Signaling Pathways in Disease (7 papers), Epigenetics and DNA Methylation (5 papers) and Peptidase Inhibition and Analysis (5 papers). Zu‐De Xu is often cited by papers focused on Signaling Pathways in Disease (7 papers), Epigenetics and DNA Methylation (5 papers) and Peptidase Inhibition and Analysis (5 papers). Zu‐De Xu collaborates with scholars based in China, United States and Canada. Zu‐De Xu's co-authors include Qingquan Li, Xiuping Liu, Jingda Xu, Wenjuan Wang, Xi-Xi Cao, Feng Tang, Qi Chen, William N. Hait, Zhongqing Chen and Hao Wu and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Zu‐De Xu

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zu‐De Xu China 19 968 558 307 153 109 28 1.3k
Ashish Juvekar United States 11 804 0.8× 468 0.8× 316 1.0× 184 1.2× 91 0.8× 22 1.3k
Wan-Ching Yen United States 17 912 0.9× 590 1.1× 232 0.8× 131 0.9× 77 0.7× 47 1.3k
Xiao-Feng Le United States 21 910 0.9× 462 0.8× 274 0.9× 111 0.7× 99 0.9× 23 1.3k
Kideok Jin United States 20 864 0.9× 580 1.0× 310 1.0× 176 1.2× 77 0.7× 28 1.3k
Olivier Meurette France 14 951 1.0× 304 0.5× 302 1.0× 164 1.1× 91 0.8× 18 1.3k
Ylenia Lombardo United Kingdom 18 815 0.8× 702 1.3× 459 1.5× 202 1.3× 85 0.8× 20 1.4k
Dekuang Zhao United States 15 723 0.7× 531 1.0× 317 1.0× 169 1.1× 75 0.7× 29 1.2k
Sophie North France 16 768 0.8× 560 1.0× 261 0.9× 102 0.7× 123 1.1× 17 1.1k
Vera Levina United States 13 581 0.6× 688 1.2× 296 1.0× 178 1.2× 76 0.7× 18 1.1k

Countries citing papers authored by Zu‐De Xu

Since Specialization
Citations

This map shows the geographic impact of Zu‐De Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zu‐De Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zu‐De Xu more than expected).

Fields of papers citing papers by Zu‐De Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zu‐De Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zu‐De Xu. The network helps show where Zu‐De Xu may publish in the future.

Co-authorship network of co-authors of Zu‐De Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zu‐De Xu. A scholar is included among the top collaborators of Zu‐De Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zu‐De Xu. Zu‐De Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Jie, Michelle Yang, Qi Ouyang, et al.. (2016). Phosphatase PPM1A is a novel prognostic marker in pancreatic ductal adenocarcinoma. Human Pathology. 55. 151–158. 10 indexed citations
2.
Li, Liliang, Pan Gao, Yuhua Li, et al.. (2014). JMJD2A-dependent silencing of Sp1 in advanced breast cancer promotes metastasis by downregulation of DIRAS3. Breast Cancer Research and Treatment. 147(3). 487–500. 32 indexed citations
3.
Yang, Haiping, Juan Yu, Lei Wang, et al.. (2014). miR-320a is an independent prognostic biomarker for invasive breast cancer. Oncology Letters. 8(3). 1043–1050. 39 indexed citations
4.
Zou, Liping, Wenjuan Wang, Zu‐De Xu, Nong Zhang, & Tao Jiang. (2012). Aldose reductase regulates platelet-derived growth factor-induced proliferation through mediating cell cycle progression in rat mesangial cells. International Journal of Molecular Medicine. 30(2). 409–416. 8 indexed citations
5.
6.
Lin, Min, Yun Bao, Qiong Li, et al.. (2010). [Relationship between breast cancer molecular subtypes with clinicopathological characteristics and prognosis].. PubMed. 39(6). 372–6. 2 indexed citations
7.
Cao, Xi-Xi, Jingda Xu, Jiawen Xu, et al.. (2010). RACK1 promotes breast carcinoma migration/metastasis via activation of the RhoA/Rho kinase pathway. Breast Cancer Research and Treatment. 126(3). 555–563. 42 indexed citations
8.
Li, Qingquan, Yanping Sun, Canping Ruan, et al.. (2010). Cellular prion protein promotes glucose uptake through the Fyn‐HIF‐2α‐Glut1 pathway to support colorectal cancer cell survival. Cancer Science. 102(2). 400–406. 55 indexed citations
9.
Li, Qingquan, Jingda Xu, Wenjuan Wang, et al.. (2009). Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells. Clinical Cancer Research. 15(8). 2657–2665. 286 indexed citations
10.
Xu, Jingda, Xiaoli Liu, Jiawen Xu, et al.. (2009). RACK1: A superior independent predictor for poor clinical outcome in breast cancer. International Journal of Cancer. 127(5). 1172–1179. 64 indexed citations
11.
Zhu, Hua, Brad R. Evans, Peter O’Neill, et al.. (2009). A role for p53 in the regulation of extracellular matrix metalloproteinase inducer in human cancer cells. Cancer Biology & Therapy. 8(18). 1722–1728. 16 indexed citations
12.
13.
Cao, Xi-Xi, Jingda Xu, Jiawen Xu, et al.. (2009). RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo. Breast Cancer Research and Treatment. 123(2). 375–386. 55 indexed citations
14.
Li, Qingquan, Wenjuan Wang, Jingda Xu, et al.. (2007). Up‐regulation of CD147 and matrix metalloproteinase‐2, ‐9 induced by P‐glycoprotein substrates in multidrug resistant breast cancer cells. Cancer Science. 98(11). 1767–1774. 51 indexed citations
15.
Li, Qingquan, Wenjuan Wang, Jingda Xu, et al.. (2007). Involvement of CD147 in regulation of multidrug resistance to P‐gp substrate drugs andin vitroinvasion in breast cancer cells. Cancer Science. 98(7). 1064–1069. 55 indexed citations
16.
Xu, Guoping, Zu‐De Xu, Bu‐Lang Gao, et al.. (2007). Cervical Actinomycosis with Spinal Cord Compression. Chemotherapy. 54(1). 63–66. 3 indexed citations
17.
Li, Qingquan, et al.. (2007). The effect of TGF-β1 and Smad7 gene transfer on the phenotypic changes of rat alveolar epithelial cells. Cellular & Molecular Biology Letters. 12(3). 457–72. 18 indexed citations
18.
Yang, Jinming, Peter O’Neill, Wei Jin, et al.. (2006). Extracellular Matrix Metalloproteinase Inducer (CD147) Confers Resistance of Breast Cancer Cells to Anoikis through Inhibition of Bim. Journal of Biological Chemistry. 281(14). 9719–9727. 95 indexed citations
19.
Xu, Zu‐De. (2005). Relationship Between the Expression of P-gp and that of CD147,MMPs in None Small Cell Lung Cancer. 1 indexed citations
20.
Qian, Liping, et al.. (2004). Effect of Allicin on the Telomerase Activity,Cyclooxygenase-2 and Nuclear Factor-kappa B of Colon Cancer Lovo Cell Line. 31(6). 597–599. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashish Juvekar Breakdown of academic impact, for papers by Wan-Ching Yen Breakdown of academic impact, for papers by Xiao-Feng Le Breakdown of academic impact, for papers by Kideok Jin Breakdown of academic impact, for papers by Olivier Meurette Breakdown of academic impact, for papers by Ylenia Lombardo Breakdown of academic impact, for papers by Dekuang Zhao Breakdown of academic impact, for papers by Sophie North Breakdown of academic impact, for papers by Vera Levina
Rankless by CCL
2026